Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Thursday 14 May 2015

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection.

Professor Sievert
William Sievert published in JAMA.

Read article here.

No comments:

Post a Comment